CONTROL OF NARCOTIC SUBSTANCES (REGULATION OF DRUGS OF ABUSE,
CONTROLLED CHEMICALS, EQUIPMENT AND MATERIALS) RULES, 2001
[Gazette of Pakistan, Extraordinary, Part II, Page No.
2735-2797, November
28, 2001]
S. R.O. 808 (I)/2000
dated 26-11-2001.---In exercise of the
powers conferred by section 77 of the Control of Narcotic Substances Act, 1997
(XXV of 1997), read with sections 4, 6, sub-section (2) of sections 7 and 10
thereof, the Federal Government is pleased to make the following rules, namely:
CHAPTER-1
PRELIMINARY
1. Short title and
Commencement. (1) These rules
may be called the Control of Narcotic Substances (Regulation of Drugs of Abuse,
Controlled Chemicals, Equipment and Materials) Rules, 2001.
(2) These rules shall
come into force at once.
2. Definitions. (1) In these rules unless there is anything
repugnant in the subject or context:‑
(i) "Act" means Control of Narcotic Substances Act, 1997
(XXV of 1997);
(ii) "analogue" means any substance
not listed in any Schedule of these rules whose chemical structure is
substantially similar to any drug of abuse whose psychoactive effect it
simulates;
(iii) "animal" includes fish, birds, invertebrates or
other fauna;
(iv) "Competent Authority" means the
authority notified in the official Gazette by the Federal Government to
discharge various functions including registration, licensing and import,
export or transit permit authorization, etc., under these rules;
(v) "controlled chemical" means a
substance listed in Schedule V and includes a controlled chemical preparation;
(vi) "controlled equipment" means anything listed as
such in Schedule VI;
(vii) "controlled material" means anything listed as
such in Schedule VI;
(viii) "Convention
State" means a State which is a party to the United Nations Convention
against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988;
(ix) "cultivate" includes planting,
sowing, scattering the seed, growing, nurturing, tending or harvesting, and
also includes the separating of opium, coca leaves, cannabis and cannabis resin
from the plants from which they are obtained;
(x) "data" means representations, in any form, of
information or concepts;
(xi) "dentist" means any person who is
registered under the Medical and Dental Council Ordinance, 1962 (XXXII of
1962), and entitled to practice the profession of dentistry;
(xii) "drug dependent person", in
relation to a drug of abuse or analogue, means any person who has such a
condition that;
(a) administration of the drug to him or her
results in the person demonstrating impaired control in relation to the use of
that drug, or drug-seeking behaviour suggesting such impaired control; or
(b) cessation of the administration of the drug
is likely to result in the person experiencing symptoms of mental or physical
distress or disorder;
(xiii) "drug of abuse" means a
prohibited drug, a high-risk drug, or a risk drug, and includes a preparation;
(xiv) "Encapsulating machine" means
any device which may be used to fill shells, capsules or other containers with
a drug of abuse or analogue in whatever physical form;
(xv) "foreign State' means:--
(a) any country other
than Pakistan; and
(b) every constituent part of such country,
including a territory, dependency or protectorate, which administers its own
laws relating to drugs of abuse, analogues, controlled equipment and controlled
materials;
(xvi) "high-risk drug" means a substance listed in
Schedule II;
(xvii) "Inspector" means any person appointed under rule
44;
(xviii) "institution" means a
hospital, nursing home or other institution
used for the accommodation, treatment and care of persons suffering
from physical or mental conditions;
(xix) "International Drug Control Conventions" means:
(a) The Single Convention on Narcotic Drugs done
at New York on the 30th March, 1961, as amended by the 1972 Protocol amending
the Single Convention done at Geneva on the 25th March, 1972;
(b) The Convention Against Phychotropic
Substances done at Vienna on the 21st February, 1971;
(c) The United Nations Convention Against
Illicit Traffic in Narcotic Drugs and Psychotropic Substances done at Vienna on
the 20th December, 1988; and
(d) any other international convention to which
Pakistanmay become party after the
commencement of these rules relating in whole or in part to the
control of drugs of abuse, controlled chemicals or controlled equipment;
(xx) "medical practitioner" means an
person who is registered under the Medical and Dental Council Ordinance, 1962
(XXXII of 1962), and entitled to practice the profession of medicine;
(xxi) "open individual authorization"
means an authorization permitting an operator to export from Pakistan such
quantities of such controlled chemicals, equipment or materials to such
countries or regions during such periods as may be specified in the
authorization;
(xxii)
"operator" means any person who carries on a business of the
manufacturer, acquisition or supply of:-‑
(a) a drug of abuse, intended for medical,
scientific use or other lawful use; and
(b) a controlled chemical or any item of
controlled equipment or controlled material, intended for lawful use;
(xxiii) "permit"
means a permit of the kind referred to in rules 12, 13, 14 or 15 of
the rules, as the case may be;
(xxiv) "person" means any natural or legal person;
(xxv) "pharmacist" means any person
who is registered under the Pharmacy Act, 1967 (XI of 1967) and entitled to
practise the profession of pharmacy;
(xxvi) "place" includes any land
(whether vacant enclosed or built upon, or not), and any premises;
(xxvii) "practitioner" means:
(a) a dentist, medical
practitioner or veterinary surgeon;
(b) any person who is entitled under the laws of
Pakistan to practice any other profession whose members may lawfully prescribe,
dispense or administer any drug of abuse;
(xxviii) "premises" includes the whole
or any part of a structure, building, aircraft, or vessel;
(xxix) "prescription" means a written
direction by a practitioner that a stated amount of a drug of abuse be
dispensed for the person named therein;
(xxx) "preparation"
means a solution or mixture, in whatever physical state, containing:-‑
(a) a drug of abuse; or
(b) a controlled
chemical;
(xxxi) "prohibited drug" means a substance specified in
Schedule I;
(xxxii) "record" means any material on
which data are recorded or marked and which is capable of being read or
understood by a person, computer system or other device;
(xxxiii) "risk drug" means a substance specified in
Schedule III;
(xxxiv) "Schedule" means a Schedule to these rules;
(xxxv) "supply" means sale,
consignment, dispatch, transport, delivery, distribution, dispensing, as well
as offer to supply;
(xxxvi) "tabletting machine" means any
device which may be used to compact of
mould a drug of abuse or analogue into a sold tablet;
(xxxvii) "toxic chemical inhalant" means a substance
specified in Schedule IV;
(xxxviii) "transit" means the physical
transfer of any drug of abuse, analogue, controlled chemical or controlled
material into, and out of the territory of Pakistan:
(a) without it passing
through Pakistan Customs; and
(b) where Pakistan is
neither its country of origin nor destination; .
(xxxix) "veterinary surgeon" means any
person who is registered under the Pakistan Veterinary Medical Council Act,
1962 (III of 1962), and entitled to practise the profession of veterinary
medicine; and
(2) The words and
expressions used but not defined in these rules shall have the same meaning as
are respectively assigned to them under the Act.
CHAPTER-2
CLASSIFICATION AND SCHEDULING OF DRGUS OF ABUSE AND CONTROLLED CHEMICALS
3. Classification of
Drugs of abuse and controlled chemicals. (1) Each of the drugs of abuse to which these
rules apply is classified by the Schedule in which it appears under its
international non-proprietary name or, lacking such a name, under its
scientific name.
(2) Different measures
of control are specified in these rules for different drugs of abuse according
to the classification so adopted, with the strictest measures being applied in
relation to drugs of abuse specified in Schedule I, less strict measures in
relation to those specified in Schedule II, and the least strict in relation to
those specified in Schedule III.
(3) Each of the
controlled chemicals to which these rules apply is classified by the divisions
of Schedule V in which it is specified.
(4) Different measures
of control are provided for in these rules for different controlled chemicals,
according to the classification so adopted in that pre-export notification of
the competent authority of exports of controlled chemicals, is required for
those controlled chemicals specified in Division I of Schedule V, measures of
control relating to registration or licensing as provided in rules 5, 6 and 7,
reporting of material changes as provided in rule 19, suspicious transactions
as provided in rule 21 and loss or theft as provided in rules 41 and 43;
documentation and labelling, record-keeping as provided in rules 26, 27, 28,
29, 30, 34 and 35 generally apply in respect of all such chemicals, equipment
and materials, and any supplementary control measures provided for in the rules
for the regulatory oversight of lawful trade in controlled chemicals,
controlled equipment and controlled
materials (open individual authorization) as provided in rule 16, or import,
export, transit or re-direction permits as provided in rules 7, 11 and 13 shall
apply only if the competent authority so determines under sub-rule (1) of rule
5.
4. Preparations. (1) Preparations shall be subject to the
same meansures of control, under these rules, as the drugs of abuse or
controlled chemicals they contain, and where any preparation contains two or
more constituent .drugs of abuse, it shall be subject to the measures governing
the most strictly controlled constituent.
(2) The Competent
Authority may, by order in writing, exempt any preparation containing:‑
(a) a drug of abuse specified in Schedule I or
III from such measure of control provided in these rules, when the Competent
Authority is satisfied that:‑
(i) the preparation is compounded in such a way
as to present no or negligible risk of abuse; and
(ii) The drug of abuse cannot be readily
recovered from it in a quantity liable to present such a risk; and
(b) a controlled chemical, when the Competent
Authority is satisfied that it is in such a state that the chemical cannot
easily be used for the illicit manufacture of a drug of abuse.
(3) The Competent
Authority shall not exempt any preparation, under sub-rule (2):-‑
(a) Insofar as it relates to the manufacture,
import or export of preparations containing high risk drugs or risks drugs, or
the making and keeping of records relating to such activities; and
(b) otherwise, except to
the extent if any to which it may be exempted under any international drug control convention applicable to the particular preparation or class
ofpreparation.
(4)
The Competent Authority shall maintain a register of the preparation exempted under this section,
specifying in relation to each such preparation each control measure from which
it is exempted.
CHAPTER-3
REGISTRATION, LICENSING ANDPERMIT SYSTEM
4. Requirement for
registration, licensing etc., of controlled chemical, equipment and materials operators. (1) To help and
ensure that there
is no significant risk that controlled chemicals, equipment and materials may be diverted from lawful use to the unlawful
manufacture of ally drug of abuse in
Pakistan or elsewhere, the Competent Authority, by notice published in the official Gazette, may determine
in relation to any operator or class
of operators which control measures, or combination of measures specified
in sub-rule (2), shall apply for the purposes of this Chapter.
(2)
The following control measures, or combination of control measures, which the
Competent Authority may determine, shall apply for the purposes of sub-rule (1) namely:-‑
(a) registration, under
rule 6;
(b) the grant of a licence, under rule 9; or
(c) in the case of import and export activities registration
or licensing, and:-
(i) an
open individual authorization issued to theoperator by Competent Authority under rule 16 for all such activities:
Provided that the Competent Authority may, by
written notice, restrict the open authorization temporarily or indefinitely, to
one of such activities, involving such chemicals, equipment or materials
or countries as the Competent
Authority may specify in the
notice;
(ii) a permit for each intended import or export
transaction, or for each transit or redirection, issued under rule 12 or 13;
(iii) an export permit for each intended export
transaction, conditional on the prior receipt of an import certificate issued by the competent
authorities of the country of
intended import; or
(iv) a pre-export notification made by the
operator to theCompetent Authority in
accordance with theprescribed form in Annexure II, within a
prescribed period before each export
transaction.
(3) In determining,
which control measure shall apply in cases under such rule (2), the competent authority
shall consider:-‑
(a) the
likely quantities and ultimate use (lawful or unlawful) of the controlled
chemicals, equipment or materials involved;
(b) in the case of transit or export, the
countries or regions to which any such chemicals, equipment or materials are
likely to be destined, particularly if they are ones in which drugs of abuse or the raw materials for making them are
believed to be illicitly
produced;
(c) the
commercial experience and integrity of operators and their staff,
including their experience in dealing with the chemicals, equipment or materials concerned; and
(d) any other relevant
matter.
(4) No operator shall
manufacture, import, export, acquire, supply or possess any controlled chemical
or item of controlled equipment or materials except in pursuance of and in
accordance with the relevant control measure determined by the Competent
Authority under sub-rule (2).
(5) The Competent
Authority may, by notification in the official Gazette, add such terms and conditions to any control measures as it
thinks fit, including those which limit or prohibit imports or
exports of specifiedchemicals or specified
quantities thereof, whether to or from specified countries, persons or classes of persons, or
during specified periods.
(6)
The Competent Authority by notice published in the official Gazette, may exempt any
operator or class of operators other than those whose business include the manufacture, import
or export of any controlled chemical, controlled equipment or controlled material
from the operation of these rules, if
satisfied, that such exemption would not give rise to any significant risk of unlawful diversion.
(7) This rule does not
apply to the following classes of persons in relation to the following
activities, except to the extent if any to which their activities include the
import or export of any controlled chemical, controlled equipment or control
led material namely:-‑
(a) a
pharmacist, acting in accordance with the norms and standards of the pharmacy profession, in the
ordinary course of compounding
and dispensing preparation containing a drug of abuse for medical, scientific or related purposes;
(b) any person who holds a license issued under
these rules to manufacture a
preparation containing a drug of abuse of which a controlled substance is an essential ingredient, in the ordinary course of such manufacture; and
(c) any person engaged in the conduct of
scientific education or research in a laboratory which is attached to a
university or hospital, and whose
activities are recognized by theCompetent
Authority, in the ordinary course of such education or research.
6. Registration of
controlled chemical, equipment and material operators. An operator, who is required to be registered
for the purposes of these rules in respect of the manufacture, import, export,
acquisition supply or possession of any controlled chemical or item of
controlled equipment or controlled material shall, before undertaking any such
activity within ten working days from
the day on which these rules come into force, intimate theCompetent
Authority in writing with the following particulars, namely:-‑
(a) the full name,
private and business address of the operator;
(b) the activity for
which registration is sought;
(c) if the operator is a company, the full name
and residential address of each
director and of the company secretary;
(d) if the operator will engage in the activity, under a
business name, that name;
(e) each controlled chemical or item of
controlled equipment or material for
which registration is sought;
(f) the address of each place where the
controlled chemical or item of control
led equipment or material is to be stored;
(g) whether
the person or if a company, any director or secretary of the
company, has ever been convicted in Pakistan or elsewhere of an offence under
Chapter II of the Act or any offence however described relating to trafficking
in drugs, controlled chemicals, controlled equipment or controlled material; and
(h) such other particulars as the Competent Authority may require.
(2) Subject to sub-rule
(3), on receipt of a notification made in accordance with sub-rule (1), the
Competent Authority shall register theoperator,
include particulars of the notification in the register, and give notice of registration to the operator.
(3) The Competent Authority may refuse to register
any operator and in case of a
company, any director or secretary of the company as the case may
be, who has ever been convicted of any offence referred to in clause (g) of sub-rule (1).
7.
Requirements of licences and permits for drugs of abuse operators. Subject to sub-rule (2), no operator shall:-‑
(a) cultivate any cannabis plant coca bush or opium poppy; or
(b) manufacture, acquire or supply any drug of
abuse, except pursuant to and in accordance with the terms and conditionsof a licence granted by the Competent Authority
under rule 9.
(2) Sub-rule (1) does
not apply to professional supply by authorized persons pursuant to such-rule (1) of rule 23.
(3) No operator shall
import, export, bring into Pakistan in tansit, or redirect from Pakistan while
in tansit, any drug of abuse, except pursuant to, and in accordance with any terms and conditions of: --
(a) a licence issued by the Competent Authority
under rule 9 authorizing the applicant
to carry out such activities in general;
and
(b) a separate import permit, export permit,
transit permit or redirection permit, as the case may be, authorizing the
applicant to carry out the specific transaction the subject of the permit application.
(4)
Nothing in sub-rule (2) shall apply in relation to any drug of abuse in transit by post or forming part of the
medical stores of any ship or aircraft.
8.
Application for operators licence. (1) An operator who is required by these rules to
be licenced shall apply in writing to the Competent Authority for the grant of a licence and shall
state:-‑
(a) the full name,
private and business address of the applicant;
(b) each activity to
which the application relates;
(c) if the applicant is a company, the full name
and residential address of each
director and secretary of the company;
(d) if the applicant proposes to engage in the
activity under a business name, that
name;
(e) the
drug of abuse, controlled chemical or item of controlled equipment
or controlled material to which the application relates;
(f) the address of each:
(i) place where the
proposed activity would be carried out;
and
(ii) premises where the
drug of abuse, controlledchemical
or item of controlled equipment orcontrolled material would be stored;
(g) the security
arrangements that would be implemented at each address;
(h) the
name; residential address and qualification of each person under whose supervision the activity would
be carried out; and
(i) such other particulars as may be prescribed
(e.g. volume estimates in the forthcoming year, and volume statistics for the past year; in the case of cultivation, e.g.,
the geographicallocation, land surface area, as well as the storage
location, and ultimate destination of the harvest; and in the case of
manufacturer the extraction, manufacturing and denaturing procedure to be used,
name and quantities of the substances and raw materials to be used, estimates
relating to each drug of abuse and preparation
produced, etc.).
2. An application for
licence shall be accompanied by:-‑
(a) a plan of each of the relevant premises,
indicating where the drug of abuse,
controlled chemical or item of controlled equipment or controlled material
would be stored, and the location and nature of any securitydevices; and
(b) the prescribed fee.
9.
Grant of licence. Where an application has been made in accordance with rule 8, the Competent Authority
may grant a licence if it is satisfied that:-‑
(a) the applicant and, if
a company, each director and secretary of the company:-‑
(i) has never been convicted in Pakistan or
elsewhere of any serious offence, or any
offence, relating to a drug of
abuse, controlled chemical or item of controlled equipment or controlled material; and
(ii) is otherwise a fit and proper person to hold a
licence;
(b) the applicant proposes
to engage in the activity;
(c) all places and premises at or in which the
activity is to be undertaken are in
fit condition and appropriate;
(f) the
security arrangements and devices proposed at each relevant place and premises are appropriate and
sufficient;
(e) the
activity shall at all times be carried out under the supervision of
a person who is a fit and proper person to carry out that supervision; and
(f) where the activity
relates to a drug of abuse, the activity shall be carried out exclusively for medical or scientific purposes.
10. Contents and
conditions of licences. (1)
A licence issued by the Competent Authority under rule 9 shall specify:-‑
(a) the full name and
address of the licensee;
(b) each activity to which
the licence relates;
(c) the drug of abuse, controlled chemical or
item of controlledequipment or controlled
material to which the licence relates;
(d) the address of each place and premises at which:-‑
(i) the licensed activity is to be carried out; and
(ii) the drug of abuse, controlled chemical or
item of controlled equipment, controlled materials is to be stored;
(e) such terms and conditions as are necessary and
reasonable for ensuring the proper:—
(i) carrying out and supervision of the licensed
activity;
(ii) establishment, maintenance and preservation
of record relating to that activity;
(iii) reporting to the Competent Authority in
relation to the carrying out of that
activity;
(iv) maintenance
and security of all places and premises at or in which the licensed activity will be carried out.
(f) in the case of an licence to
import, export or bring to Pakistan
in transit a drug of abuse, controlled chemical or item- of controlled
equipment of controlled material, the condition that a separate import, export
or transit permit be first obtained in
relation to any such transaction before it takes place; and
(g) such other particulars as the Competent
Authority may, by order in writing,
require.
11. Applications for
import, export or transit permits. (1) An application
for an import, export or transit permit shall be made in writing to the
Competent Authority specifying therein:‑
(a) the full name and address of the importer,
exporter, carrier, consignee and, if
known, of any ultimate consignee;
(b) in the case of a proposed import, export or transit of a drug of abuse:‑
(i) its
international non-proprietary name or failing this, its name as listed in Schedule II or III,
together with its trade name, if it has one; and
(ii) its pharmaceutical form;
(c) in the case of proposed
import, export or transit of a controlled chemical, the name as specified in
Schedule V and
trade name;
(d) in the case of a
proposed export of a drug of abuse, the intended point of entry in the foreign State
of intended import;
(e) the quantity, mass and volume or per cent in
mixture of any drug of abuse,
controlled chemical or controlled material that is the subject of the proposed
operation;
(f) a description quantity and type of any
controlled equipment that is the
subject operation;
(g) the date, or period within which, the
planned import, export or transit is to
take place;
(h) the planned transport route, if known,
including the planned point of entry
or exit from Pakistan; and
(i) in
the case of a proposed import of a drug of abuse to a bonded warehouse, the identity and address of
the warehouse.
(2)
In the case of proposed export of a drug of abuse, the import permit, by whatever name
described, issued by the Government of the foreign State of intended import shall be
attached to the application for export permit.
12.
Grant of import, export or transit permits.(1) The Competent Authority may, on written application made in
accordance with rule 11 by a registered or licensed importer or licensed
exporter, grant an import permit, export permit, or transit permit as the case
may be, in relation to a specified import
or export transaction involving a drug of abuse, controlled chemicalor item of controlled equipment or controlled
material.
(2) An import permit,
export permit or transit permit granted under sub-rule (1) may allow import, export or transit in more than oneconsignment.
(3) The Competent
Authority shall not grant an export permit in relation to any consignment of a
drug of abuse to a bonded warehouse in aforeign
State, unless the competent authority of that State has certified on the import permit referred to in sub-rule (2)
of rule 11 that it has approved the import to a bonded warehouse.
(4) An import permit,
export permit or tansit permit shall specify:‑
(a) the
full name and address of the registered or licensed operator to whom it is granted;
(b) the name, including any international
non-proprietary name and trade name, quantity and form of any drug of abusecontrolled chemical or item of controlled equipment
or controlled material for
which it is granted;
(c) in the case of an import permit:‑
(i) the name and address of the exporter; and
(ii) whether the import is to be effected in a
single consignment or more than one
consignment.
(d) in the case of an export permit:‑
(i) the name and address of the immediate
consignee, and if known, of the
ultimate consignee;
(ii) the number and date of any required import
permit, affirming that the import of the drug of abuse or preparation has been authorized;
(iii) the intend point of entry in the foreign State
of import; and
(iv) if the export consignment is intended for a
bonded warehouse and is not prohibited under sub-rule (3), that the consignment is to be so exported.
(e) the period during
which import or export is to be made;
(f) in the case of an
intended import to a bonded warehouse a term that:‑
(i) any
subsequent withdrawal from the bondedwarehouse
shall require a permit from the Competent
Authority; and
(ii) if
the withdrawal is intended for a foreigndestination, a separate export
permit shall be first obtained prior
to export;
(g) such terms and conditions as the Competent
Authority may consider necessary and
reasonable; and
(h) such other particulars as the Competent
Authority may, by order in writing,
require.
13. Redirection permits. (1) The Competent Authority may, on production by a licensed operator of a valid
import authorization issued by an authority
in the foreign State to which it is proposed to redirect a drug of abuse or controlled chemical, issue a redirection
permit in respect of the drug of abuse or controlled chemical in transit.
(2) A redirection permit
shall specify:‑
(a) the
full name and address of the registered or licensed operator to whom it is granted;
(b) the name, including any international
non-proprietary name and trade name, quantity and form of any drug of abuse,controlled chemical or item of controlled
equipment or controlled
material for which it is granted;
(c) the
name and address of the immediate consignee and if known, of the ultimate consignee;
(d) the number and date of any required import
permit affirming that the import of
the drug of abuse or controlled chemical or item of controlled
equipment or controlled material has beenauthorized;
(e) the intended point of
entry in the foreign State of import;
(f) if
the export consignment is intended for a bonded warehouse and is
not prohibited under sub-rule (3), that the consignment is to be so exported;
(g) the period during
which import or export is to be made;
(h) in the case of an intended import to a bonded warehouse, a
term that:‑
(i) any subsequent withdrawal from the
bonded warehouse shall require a
permit from the Competent
Authority; and
(ii) if the withdrawal is
intended for a foreigndestination, a separate
export permit shall be first obtained
prior to export;
(i) such terms and conditions as the Competent
Authority may consider necessary and
reasonable; and
(ii) such other particulars as may be prescribed.
(3)
The Competent Authority shall not issue a redirection permit under sub-rule (1) unless it is satisfied that
the drug of abuse or controlledchemical is
to be sent to the new country of destination in a lawful manner and for a proper purpose.
14. Permits in relation
to first-aid kits. (1)
The Competent Authority may, on
written application made in the prescribed form, grant a permit to include a
drug of abuse in a first-aid kit for medical use during international flights or voyages.
(2) A permit to include
a drug of abuse in a first-aid kit shall specify:-
(a) the full name and
address of the authorized person;
(b) the name and maximum quantity of the drug of
abuse that may be kept in the first
aid kit at any one time;
(c) such
terms and conditions as are necessary and reasonable to ensure the proper use and usage keeping of the drug
of abuse; and
(f) such other particulars
as may be prescribed.
15. Permits in relation
to programmes for medical and scientific purposes. (1) The Competent Authority may, on written
application made in the prescribed form by a person, grant a permit to conduct
a programme for scientific or strictly limited medical purposes that would
require cultivation of:‑
(a) a drug of abuse; or
(b) an analogue;
(2) An application to
conduct such a programme shall specify:‑
(A) the
full name, address, academic, professional of other relevant qualifications of the applicant;
(B) the drug of abuse or analogue in relation to which the
permit is sought;
(c) the strength and form
in which the drug of abuse or analogue us to be used;
(d) the
maximum quantity of the drug of abuse or analogue to be possessed at any one time, and the total quantity
to be possessed during the
period of the programme;
(e) details of the manner
in which the drug of abuse or analogue would be used;
(f) the name and address
of the place where the programme is to be conducted;
(g) the name and academic, professional or other
relevant qualifications of any person other than the applicant, underwhose supervision the programme would be
conducted; and
(h) the
security arrangements that would be undertaken while the drug of
abuse or analogue is possessed, used or disposed of.
(3) An application to
conduct such a programme shall be accompanied by:‑
(a) a written description
of the programme, including its estimated
duration;
(b) in the case of a
programme of research, a research protocol;
(c) in the case of a
clinical trial, a clinical trial protocol; and
(d) a written statement approving the programme,
signed by the person Incharge of the
institution.
(4) The Competent
Authority may authorize such a programme if satisfied that:‑
(a) the
programme cannot be carried out satisfactorily without the use of the specified drug of abuse or
analogue;
(b) the programme is scientifically viable having regard to
any relevant protocol;
(c) the applicant is a fit
and proper person to conduct the programme;
(d) the programme will be
adequately supervised; and
(e) the programme is to be conducted at or under
the auspices of a recognized
institution.
(5) A permit shall
specify:-‑
(a) the full name and
address of the authorized person;
(b) the drug of abuse or
analogue to which the permit relates;
(c) the strength and form
in which the drug of abuse or analogue may be used;
(d) the maximum quantity of the drug of abuse or
analogue that may be possessed at any one time, and the total quantity
that may be possessed during the
period of the programme;
(e) the purpose for which
the permit is granted;
(f) the institution in relation to which the permit is granted;
(g) such conditions as are
necessary and reasonable for ensuring:
(i) the proper use and
safe-keeping of the drug of abuse or
analogue; and
(ii) that proper records are kept concerning its
receipt, use and disposal;
(h) the condition that such
reports, as the Competent Authority may specify, are sent to him or her on the use of the drug
of abuse or analogue in the programme,
including particulars of the quantities acquired, used, disposed of and still
hold; and
(i) such other
particulars as may he prescribed.
16. Open individual
authorization for certain exports of controlled chemicals, etc. (1) Where an operator is required under
rule 5, sub-rule (1) to hold an open
individual authorization issued by the Competent Authority, the
operator shall, before undertaking any activity for which the authorization is
required/within ten days from the day on which these rules come into force, intimate the Competent Authority
in writing of stating therein:‑
(a) the full name, private
and business address of the operator;
(b) the activity for which
authorization is sought;
(c) if the operator is a company, the full name
and residential address of each
director and secretary of the company;
(d) if the operator
engage in the activity under a business name, that name;
(e) each
controlled chemical or item of controlled equipment or material for which
authorization is sought;
(f) details
of the operator's commercial experience relevant to the controlled
chemicals, equipment of materials concerned and of each person under whose supervision the activity will be carried out;
(g) details in summary form of export
transactions in the relevant chemicals, equipment of materials during the
preceding twelve months, specifying
the country of export in relation to each chemical or item of
equipment or material exported, the
total quantities and total number of transactions involved; and
(h) such other
particulars as may be prescribed.
(2) Subject to sub-rule
(3), on receipt of an application made in accordance with sub-rule (1), the Competent Authority may :—
(a) grant an open
individual authorization; and
(b) subject the authorization to such terms and conditions as
it thinks fit.
(3)
The Competent Authority may refuse to grant the open individual authorization,
if the operator, or if a company, any director or secretary of thecompany has ever.‑
(a) failed to comply with a provision of these
rules or any other law in Pakistan
relating to an drug abuse, controlled chemical or item of
controlled equipment or material; or
(b) been
convicted in Pakistan or elsewhere of any serious offence of any
offence relating to trafficking in drugs, or controlled chemicals, equipment or material.
17. Extended
Authorization for Related Activities. Where a person is registered or licenced, or holds a permit or authorization under these
rules in relation to any activity, the person shall, subject to these rules and
to any terms and conditions of the licence, permit or authorization, be deemed to be entitled to possess the relevant drug
of abuse, analogue, controlled
chemical or item of controlled equipment or material for thepurpose of that activity.
18. Duration of
registration, licences, permits and open individual authorizations. (1) A registration or licence shall remain in
force for a period of one year, unless
earlier surrendered, suspended or revoked, and may successively renewed for a period of one year on application
in writing, signed by the
applicant and accompanied with the prescribed fee.
(2) A permit or open
individual authorization shall only remain in force for such period as may be
specified in it, which in the case of an import permit export permit or transit permit shall not exceed six months.
19. Duty of authorized
persons to notify material changes, etc. (1) Where, in relation to any licence or permit
granted to an person under these rules, a material change occurs in the:‑
(a) name or address of the person, or in the
case of a company, of any director or
secretary of the company;
(b) address of the place
or premises where:‑
(i) the licensed or
permitted activity is carried out; or
(ii) any drug of abuse, controlled chemical or
item of controlled equipment or
material is stored;
(c) raw
materials, or manufacturing or denaturing processes used in the licenced manufacture of any drug of
abuse;
(d) security arrangements
implemented at any relevant address;
(e) identity of persons under whose supervision
the licensed activity is carried out;
or
(f) planned transport route, including the
planned point of entry or exit from
Pakistan or any import, export or transit consignment for which a
permit has been granted under sub-rule (1)
of rule 12;
the person shall, within fourteen days of its
occurrence, furnish the Competent
Authority with a written noticecontaining full particulars of the change,
and shall return to the Competent Authority any licence or permit issued
under these rules.
(2) Where, in relation
to any registration or open individual authorization granted to any person under these rules, a material
change occurs in the:‑
(a) name or address of the person, or in the
case of a company, of any director or
secretary of the company; or
(b) address of the place
or premises where:-
(i) the registered or authorized activity is carried
out; or
(ii) the
controlled chemical, or item of controlled material or equipment is stored;
the person shall, within
fourteen days of itsoccurrence, furnish with
the Competent Authority with a written
notice containing full particulars of the change.
20. Variation,
suspension or revocation of registration, licences, permits or authorizations. (1) If,
at any time after the grant of a licence, permit, registration or open individual authorization, it appears to
the Competent Authority that:‑
(a) it was granted on the basis of information
that was false or misleading in a
material particular;
(b) a
material change of circumstances referred to in rule 19 has occurred since it was granted, whether notified
under that rule or not;
(c) a condition to which it was subject has not been complied
with; or
(d) the
person has been charged or convicted of an offence against the rules, or of a serious offence,
the
Competent Authority may as it thinks necessary and reasonable in all the circumstances
to prevent the risk of unlawful diversion:-
(i) impose conditions, or vary any existing
conditions specified in the licence,
permit or authorization, within
twenty-eight days of the date of issue of a notice of variation;
(ii) suspend
the registration, licence, permit orauthorization for such period as the
Competent Authority deems fit; or
(iii) revoke the registration, licence, permit or authorization.
(2)
Any person whose licence, permit or authorization is suspended or revoked under sub-rule
(1) shall return it to the Competent Authority within two days after the Competent Authority
notifies the person in writing of the
revocation or suspension.
21. Duty of operators to
check and notify suspicious orders and transactions. (1) Whenever an operator:‑
(a) is registered, licenced, permitted or authorized under
these rules;
(b) receives
an order or becomes party to a transaction involving a drug of
abuse, controlled chemical or item of controlledequipment or materials; and
(c) has reasonable grounds to suspect that
information, which is concerning the order or transaction may be relevant to an
offence provided in Chapter II of the Act, the operator shall, immediately after forming that suspicion,
communicate to the Competent Authority the particulars of the
suspicion, the basis of it, and such other information, if requested, as
the person has in relation to the
order or transaction.
22.
Power to limit licensee's stocks. (1) On or before the 31' day of December each year, the Competent Authority
shall, in the light of the prevailing market conditions determine the maximum
quantities, if any, of each drug of abuse, controlled chemical, that each
operator licensed under Chapter I of these rules may manufacture or stock for
the normal conduct ofits business during
the following year.
(2) The Competent
Authority may, at any time amend any quota determined under sub-rule (1), and
shall promptly intimate each licensee inwriting
of the amended quota.
(3) The Competent
Authority may, if satisfied that a person authorized to stock a drug of abuse
holds a quantity in excess of the annual quota
as revised in accordance with sub-rule (2), it may requisition the surplus quantity upon payment of an amount not
less than the amount paid by the person to acquire it.
CHAPTER-4
PROFESSIONAL SUPPLY OF DRUGS OF ABUSE
23.
Persons authorized to engage in professional supply of drugs of abuse. (1) No person shall engage in conduct that
constitutes professional supply of any drug of abuse except:‑
(a) a pharmacist, acting in accordance with the
norms and standards of the pharmacy profession, who supplies to another person
on prescription or on requisition, in the ordinary course of a pharmacy business;
(b) a person licenced under clause (b) of
sub-rule (1) of rule 7; provided that such supply at all times takes place
under theimmediate supervision of a
pharmacist;
(c) a
practitioner who, in accordance with the norms and standards of his
or her profession:‑
(i) administers
the drug directly to a patient or animal in the ordinary course of
treatment; or
(ii) supplies the drug to a patient or for an
animal in the ordinary course of treatment from a place more than ten kilometers from the place of business of apharmacist.
(2)
Notwithstanding anything contained in sub-rule (1), where access to a practitioner is not reasonably
possible by virtue of distance, the Competent Authority may authorize a licensed retail distributor to
supply a drug of abuse without
prescription, in exceptional cases for use by individuals in small quantities for exclusively
medical purposes.
24. Prescriptions. No person shall prescribe a drug of abuse,
unless that person is:‑
(a) a medical practitioner, who prescribes the
drug of abuse in the ordinary course of treatment of another person's
physical or mental condition;
(b) a dentist, who prescribes the drug of abuse
in the ordinary course of treatment of another person's mental condition;
(c) a
veterinary surgeon, who prescribes the drug of abuse in the ordinary course of treatment of an animal; or
(d) a person or class of persons which the
Competent Authority may authorize, from time to time, for the purposes of
these rules to prescribe certain drugs
of abuse in places where access
to a practitioner is not reasonably possible.
(2) A person referred to
in sub-rule (1) shall not except in:‑
(a) a medical emergency;
or
(b) in the ordinary
course of treatment;
prescribe a drug of abuse to a person who, he
has reason to believe, may be a drug dependent person, without the priorwritten approval of the Competent Authority.
(3) Subject to sub-rule
(4), a prescription for a drug of abuse shall:‑
(a) be on a form
prescribed by the Competent Authority;
(b) be legible;
(c) be
written in terms and symbols used in ordinaryprofessional practice;
(d) specify the name, address, qualifications
and registration number of the
prescribing practitioner;
(e) specify
the date on which it is issued if different from the date on which
it was signed, and the period during which it may be filled;
(f) specify the name and address of the patient,
or the owner of the animal being
treated, as the case may be;
(g) specify the name, quantity, form and strength of the drug
of abuse;
(h) specify the number of
times up to a maximum of the three time, the drug of abuse may be refilled and,
if more than once,
than the interval to elapse between dispensing;
(i) if
the prescription is for an unusual or dangerous dose, it shall bear the initials of the prescribing
practitioner beside an underlined reference to the dose;
(j) if the prescription is issued by a veterinary surgeon:‑
(i) be endorsed as being for the treatment of an
animal;
(ii) specify
the name and address of the owner orcaretaker
of the animal;
(iii) specify the species of animal;
(iv) specify means of identifying the animal; and
(k) be signed with date
by the prescribing practitioner.
(4)
Where the need for treatment is urgent, a prescription may be given orally and acted
upon; provided that is confirmed by a written prescription within
twenty-four hours.
25. Requisitions in an
institution for purpose of treatment. (1) No person shall issue a requisition for a drug of abuse
unless the person is:-‑
(a) a pharmacist in a
dispensary in an institution;
(b) a practitioner
practising in an institution; or
(c) a person in charge of
a ward in an institution.
(2) A person shall not
supply a drug of abuse against a requisition, except to a person referred to in sub-rule (1), at an institution for
the treatment of a person
therein.
(3) Subject to sub-rule
(4), a requisition for a drug of abuse shall:‑
(a) be legible;
(b) specify the name of the person issuing it
and the capacity in which he or she
issues it;
(c) specify the name, quantity, form and strength of the drug
of abuse;
(d) specify the ward or
dispensary where the drug is required;
(e) be signed with date
by the person issuing it; and
(f) be
countersigned by either the pharmacist who is to supply the drug of
abuse, or a medical practitioner.
(4) Where the need for
the drug of abuse is urgent, a requisition may be given orally and acted upon;
provided that, it is confirmed by a written requisition within twenty-four
hours.
CHAPTER-5
COMMERCIAL DOCUMENTATION AND LABELLING, RECORDS AND SECURITY
26. Commercial
documents. Any commercial document,
such as an invoice, cargo manifest or a customs, transport and other shipping
document, relating to any transaction by an operator involving a drug of abuse,
controlled chemical or item of controlled equipment, shall include:-‑
(a) the
name and quantity of the drug of abuse, controlled chemical or item
of controlled equipment as specified in the relevant Schedule; and
(b) in the case of any import or export, the
name and address of the exporter, the importer and, where known, the consignee.
27. Forwarding of import
permit in advance to proposed foreign exporter. Where the Competent
Authority issues an import permit under these rules to an operator, the operator shall, as soon as
possible but no later than five working
days after its receipt forward the permit to the exporter named in
the permit.
28. Export permits to be
attached to consignments.
Where the Competent Authority issues an export permit under these rules to an
operator, the operator shall attach an authenticated copy of the permit to each
consignment on export.
29. Endorsement and
return of export permits following import. After an importedconsignment has entered Pakistan or when the period stipulated
in the import permit expires, the Competent Authority shall cause the export
permit issued by the Competent Authority of the exporting country or territory to be returned to that authority,
with an endorsement specifying the
quantity of each drug of abuse or controlled chemical, equipment or material
actually imported.
30. Forwarding of
redirection permits, etc. (1)
Where a redirection permit is issued under sub-rule (1) of rule 13:--
(a) one copy shall accompany the drug of abuse
or controlled chemical when it is
exported from Pakistan; and
(b) the Competent Authority shall cause another
copy of the redirection permit to be sent forthwith, upon issue to theauthority in the foreign country to which the
consignment has been redirected.
(2) Upon the issue of a
redirection permit, any person holding the export permit or redirection permit accompanying the drug or chemical, onits
arrival in Pakistan shall remit it to the Competent Authority who shall return
it to the Competent Authority issuing it together with:-‑
(a) a notice of the name of the foreign country
to which the consignment has been
redirected; and
(b) an
endorsement specifying the quantity of each drug of abuse or controlled chemical, equipment or
material actually imported.
31. Liability to
forfeiture of improperly or undocumented consignments. (1) A consignment of a drug of abuse or
controlled chemical, equipment or material is liable to forfeiture if:‑
(a) it is accompanied by an export permit or
redirection permit, and there are
reasonable grounds to believe that the permit is false, or has been obtained by fraud or wilfulmisrepresentation of a material particular;
(b) there
are reasonable grounds to believe that any import permit relating to it is false; or
(c) in the case of a consignment of a drug of
abuse, it is not accompanied by any
export or redirection permit.
(2)
Where the Competent Authority is satisfied that any consignment referred to in sub-rule (1) is legitimate, the
consignment shall be releasedforthwith to
the person lawfully entitled to it.
32. Restriction for
further import permit. If an import permit has already been issued, to an operator for a
specific drug of abuse, controlledchemical,
equipment and material, no further import permit for the same shall
be issued to the same person unless the items covered by the earlier, permit
have been actually imported and report regarding its import has been sent to the Competent Authority.
33.
Importation or exportation by post.(1) All permits issued under these rules shall, save where import or
export is authorized by post, be prominently marked 'NOT AVAILABLE BY
POSTS".
(2) Save as provided in
sub-rule (3), the medium of the post office shall not be used for import into,
or export from, Pakistan by sea or by land, of any drug of abuse, or controlled
chemicals, equipment and material.
(3) Where any drug of abuse, or controlled chemicals,
equipment and material is to be
imported or exported in accordance with these rules by air for urgent reasons, the import or export permit
may be marked"AVAILABLE BY PARCEL BY AIR".
(4) Disposal of export authorization issued by foreign
authority. When the importation of a drug of abuse, or controlled
chemicals, equipment and material has been effected or when the period fixed
for importation has expired, the importer shall submit to the Competent
Authority the export authorization, on
the basis of which the import permit was granted to him, and
thereon the Competent Authority shall . return the authorization with
endorsement to the effect that the quantity of the drug as specified in the
endorsement has actually been imported, or, as the case may be, that the
said period has expired.
35.
Quantity actually exported. If a lesser quantity, than that specified in an export
permit, is actually exported, the quantity actually exported shall be stated by the Customs
authorities on the export permit and on
any official copy thereof.
36.
Trans-shipment. (1)
Subject to the provisions of section 72 of the Act and these rules, no drug of abuse, or controlled
chemicals, equipment and material, as specified in the schedules of these rules,
shall be transshipped at any port save with the permission of the Collector of
Customs.
(2) The Collector of
Customs shall not grant the permission, referred to in sub-rule (1), save under
the special order in writing of the Competent Authority in each ease, unless:
(a) the country from which the drugs or
substances have been shifted and country to which the drugs or the substances
areconsigned are signatories to and have
ratified the UN Conventions of 1961, 1971 and 1988, on NarcoticsDrugs/Psychotropic Substances; and
(b) the
drug are covered by an export authorization or a diversion
certificate granted in accordance with Article 31 of the Single Convention on Narcotics Drugs 1961 by
or under the authority of the Government of the country from which
they have been shipped and such authorization or certificate is produced for
inspection of the Collector of Customs
in accordance with the said Article 31.
37.
Processing or alteration or packing. No consignment of drug of abuse, or controlled chemicals, equipment and
material while in transit or while
stored in a bounded warehouse, shall be subjected to any processwhich would change the nature of the drugs, nor
shall the packing of any such consignment be altered without the
permission, in writing, of the Competent
Authority.
38.
Drugs of abuse registers. (1) The following persons shall keep, or cause to be kept, at a place where any drug
of abuse is kept, a register in the
manner determined, from time to time, by the Competent Authoritynamely:-‑
(a) any
person granted registration, or a licence or a permit under these rules in relation to any drug of
abuse;
(b) any
person authorized under these rules to issue a prescription or
requisition for a drug of abuse, or to supply such a drug by retail;
(c) any pharmacist, including a pharmacist
responsible for the supervision of all other pharmacists employed in a
hospital or other institution for
medical treatment or care; and
(d) any duly qualified person, for the time
being, in-charge of ward or other area
of an institution in which any drug of abuse is administered.
(2) A person required by
sub-rule (1) to keep, or cause to be kept, a register in relation to any drug of abuse, shall within twenty-four hours
of any import, export,
manufacture, administration, supply, acquisition, disposal or
return of such drug enter or cause to be entered in the register:‑
(a) the date of the import, export, manufacture,
administration, supply, acquisition,
disposal or return;
(b) the name, quantity, dosage, form and
strength of the drug, imported, exported, manufactured, administered, supplied,acquired, disposed of or returned;
(c) the name and occupational or business
address of the person to or from whom the drug was imported, exported,
supplied or acquired;
(d) in case of export or supply, the quantity of the drug, if
any, still kept;
(e) in
case of supply on prescription for the purpose oftreatment, or of
administration of a drug of abuse for that purpose:-
(i) the name and address of the person who prescribed the drug or ordered its administration;
(ii) the name and residential address of the
person for whom or to whom the drug was
supplied or administered, or
where prescribed or administered to an animal, the name of the
person having custody of the animal at
the time;
(iii) the name and residential address of the
patient to whom the drug was prescribed, if different from the person referred to in sub-clause (ii); and
(iv) where
applicable, the name and address of anyperson other than the treating
practitioner who administered the drug,
the time of administration, and particulars sufficient to identify
any animal for whose treatment the drug
was administered or prescribed
or supplied on prescription;
(f) in the case of supply on requisition in an
institution, details of the dispensary, ward or other place to which the drug
was supplied;
(g) in
the case of return, the name of the person to whom the drug was returned; and
(h) in the case of
disposal:-
(i) the method of disposal; and
(ii) the signature, name and
designation of the personresponsible
for the disposal, and of at least one witness to the disposal.
(3) A person who makes
an entry in a drugs register shall sign the entry, with date.
(4) A person may, in the presence of a witness,
correct, by notation, a mistake
in an entry in a drugs register, provided the person making the correction
makes, signs and dates the notation, and the witness countersigns the notation.
(5) Any person who:—
(a) delivers a drug of abuse to a ward or other area of an institution; or
(b) in the ordinary course of duties in a
medical, dental or veterinary practice, or in a ward or other area of an
institution, witnesses the administration of that drug,
shall countersign the relevant entry in the drugs
register.
(6)
Any person required by these rules; to keep a drugs of abuse register shall, subject to
any written direction to the said person by the Competent Authority, retain possession of the
register and all prescriptions, requisitions and commercial documents relating
to entries therein for three years after the date of the last entry in the
register.
39.
Controlled chemicals, equipment and materials registers. (1) Any person granted
registration, licence, permit or open individual authorization under these rules in relation to
any controlled chemical or item of controlled equipment or material skill keep,
or cause to be kept, at a place where
any such chemical or item is kept by that person, a register in accordance
with the form prescribed from time to time by the Competent Authority.
(2) Any person required
under sub-rule (1) to keep and maintain a register in relation to any controlled chemical or item of
controlled equipment or material, shall, within twenty-four hours
of any import, export,manufacture, supply,
acquisition or disposal by that person of any such chemical or
item, enter or cause to be entered in such register:--
(a) the
date of the import, export, manufacture, supply, acquisition or. disposal;
(b) the name of the chemical equipment or material, and the quantity involved;
(c) in the case of a
controlled) chemical, its form and strength;
(d) in the case of
disposal, the method of disposal; and
(e) in the case of import, export, acquisition
or supply, the name and occupational or
business address of the person to, or from whom the chemical has been acquired, documents shall be
kept for at least three; years after the end of the calendar year of the last
entry in the register.
(3)
Any register required to be kept under sub-rule (1), and all commercial documents relating to entries therein
such as orders, invoices, dispatch notes, cargo manifests or customs or other
shipping documents shall be kept for at least three years after the end of the
calendar year of the last entry in the
register.
40.
False or misleading entries in registers and records. Any person required to keep a register or other
record under these rules shall not:‑
(a) make,
or cause of permit to be made, an entry which is, to the knowledge
of that person a false or misleading in any material particular; or
(b) cancel,
obliterate or alter any entry, except to correct an error in accordance with sub-rule (4) of rule 38.
41. Duty to report and
record loss, destruction or discrepancies in registers. Any person, required to keep a register under
these rules, shall forthwith: -
(a) report the loss or destruction of the
register, or of the whole or any part
of the contents of the register; or
(b) record
any discrepancy in the register, other than a mistaken entry and
shall report to the Competent Authority in writing accordingly.
42. Safe keeping of
drugs of abuse. (1) Any person
authorized:-‑
(a) to import, export, manufacture, administer,
supply or acquire a drug of abuse or
controlled chemical accordance with these rules; or
(b) to engage in
professional supply in accordance with rule 23,
shall, while the drug or
chemical is in the person's custody or control, keep it or cause it to be kept in vault, safe or
other prescribed secure storage;
(2) A person, referred
to in sub-rule (1), shall take such measures as the Competent Authority may direct, in writing, to ensure that no unauthorized
person has:‑
(a) access
to the combination, key or other means of access to any secure receptacle containing a drug of abuse
or controlled chemical; or
(b) the drug or chemical
contained therein.
43. Duties where there
is loss or theft of a drug of abuse or controlled chemical. Any person authorized:--
(a) to
import, export, manufacture, administer, supply or acquire a drug,
of abuse or controlled chemical in accordance with these rules; or
(b) to engage in
professional supply in accordance with rule 23;
shall, immediately upon becoming aware of the
loss or theft of any quantity of the
drug or chemical in the person's custody or control shall:‑
(i) if
the person believes on reasonable grounds that the drug or chemical has been stolen,. he shall immediately
inform an Inspector and an authorized officer
orally, and report the matter in writing within twenty-four hours;
(ii) in the case of loss, give a written report
of thecircumstances of the loss to an
Inspector; and
(iii) record relevant
particulars of the loss of theft in the register.
CHAPTER 6
INSPECTION FOR COMPLIANCE
44.
Appointment of Inspectors. (1) The Competent Authority may, by notification in the official Gazette, appoint
any person to be an Inspector for the
purposes of the rules.
(2) An Inspector shall
perform such duties for the purposes of the rules as the Competent Authority may direct.
(3) The Competent Authority shall cause to be issued
to an Inspector an identity card which states the name and
appointment of the Inspector and on
which shall appear a recent photograph of the Inspector.
45.
Inspection of authorized premises and operations. A person who is registered, or holds a licence or permit
issued under these rules shall, when required to do so in writing by an
Inspector, provide the Inspector with a statement in writing, signed and dated
by the person, accounting for each drug
of abuse, controlled chemical or item of controlled equipment ormaterial
in possession of the authorized person at any time since the grant of the registration, licence, or permit, as the case
may be.
46. Powers of
Inspectors. (1) A person appointed
as an Inspector by the Competent Authority pursuant to rule 44 may, at any time
during ordinary business or professional hours, with such assistance and by
suchforce as is necessary and reasonable,
enter any premises or place at which any activity is carried out by
any person who has been:‑
(a) granted a
registration, licence or permit under these rules; or
(b) authorized
in accordance with rule 23 to engage in professional supply.
(2) Subject to rule 47,
an Inspector who enters any premises or place pursuant to sub-rule (1) may:‑
(a) require the occupier of
the premises to supply his or her name
and address;
(b) inspect the premises or place in order to
ascertain whether or not the rules or terms or conditions of any licence or
permit granted pursuant to the rules has been or is being complied with;
(c) examine
any label, advertising material, register, record, book, electronic data or other document therein
relating to any drug of abuse, controlled chemical or item of
controlledequipment or material;
(d) make
an extract therefrom or take a copy thereof, and require from any person an explanation of an entry in any
such register, record or
document;
(e) open and examine any receptacle or package
found in that place in which a drug of
abuse, analogue, controlledchemical or item of controlled equipment may
be found;
(f) examine any thing found in that place that
is used or may be capable of being used
for the manufacture, packaging or storage of a drug of abuse,
analogue, controlled chemical or item
of controlled equipment or material;
(g) use or cause to be used any computer system
at that place to examine any electronic
data referred to in clause (c) or (0, and reproduce any document from any such data or cause it to
be reproduced in the form of a print out or other output;
(h) take anything referred
to in clause (c) or (0 for examination or copying;
(i) use
or cause to be used any copying equipment at that place to make copies of any
document;
(j) examine an substance found in that place and
take, for the purpose of analysis, such samples thereof as are reasonably required;
(k) seize
and detain anything, which in the opinion of the Inspector, is
connected with or may provide proof of a contravention
of the rules or a term or condition of any licence or permit
granted under the rules and which theInspector
believes on reasonable grounds is necessary for the purpose of ensuring compliance with the rules or
the regulations.
(3) Where an Inspector seizes and detains any substance
suspected to be a drug of abuse, analogue, controlled chemical or
item of controlled equipment or
material, he may, at his discretion, be kept or stored at the place from where it was seized or be removed to any
other proper place.
(4) Where an Inspector
determines that for the purpose of ensuring compliance with these rules, it is
no longer necessary to detain a substance suspected to be a drug of abuse,
controlled chemical or item of controlled equipment or material under clauses (j), (k) of sub-rule (2), the
Inspector shall notify in writing to the owner or other person incharge of the
placewhere it was detained of that determination and, on being issued a
receipt therefor shall return the
substance to that person.
(5) Where in the
ordinary course of duty, an Inspector becomes aware of a possible offence against the Act, he or she shall immediatelyreport
that fact to the Anti-Narcotics Force and provide such further lawful assistance as may be reasonable or necessary for
the purpose of any investigation
or proceeding relating to that possible offence.
47.
Inspectors to produce authority. (1) An Inspector exercising any powers
conferred under rule 46 shall produce his or her identity card issued under sub-rule (3) of rule 44 to the
person in charge of any place in which the Inspector entered in pursuance of
the rules for the purposes of inspection.
(2) An Inspector who
enters premises in accordance with these rules is not authorized to remain on
the premises, if, on request by or on behalf of the occupier of the premises,
the Inspector does not produce the identity cardissued under sub-rule (3) of rule 44, any person on the premises is
not obliged to comply with that
order of the Inspector.
48.
Obstruction of Inspectors, etc. No person shall, without reasonable excuse, by an
act or omission:-
(a) obstruct or hinder an Inspector in the
exercise of the powers or performance of
the duties of the Inspector under these rules or regulations; or
(b) refuse or fail to comply with a reasonable
request of an Inspector who has entered any premises in accordance with these rules.
CHAPTER 7
MISCELLANEOUS
49. Repeal and savings. (1) The Dangerous Drugs (Import,
Export and Trans-shipment) Rules,
1967, are hereby repealed.
(2) The repeal of the
rules referred to in sub-rule (1) shall not affect anything done action taken
or penalty incurred under the said rule or any investigation or legal
proceeding in respect of such penalty; and any such investigation or legal proceeding may be
instituted, continued or enforced and any such penalty may be
imposed as if these rules had not been made.
50.
Supply of data to Anti-Narcotics Force. The Competent Authorities designated under
these rules shall arrange to supply on regular basis all relevant data on
the registration/licensing of various operators, issuance of import/export/transit/redirection
and other relevant permits under these
rules to the Anti-Narcotics Force, in order to meet Federal Government's
obligations under UN Conventions of 1961, 1971 and 1988 onNarcotics Drug and Psychotropic substances
regarding supply of relevant data to the international agencies
like INCB, UNDCP and Interpol.
SCHEDULE –I
[See clause (XXX) of rule-21]
PROHIBITED
This Schedule includes:-
(i) the following substances, designated by
their international non-proprietary names or the names used in the
international conventions in force;
(ii) their isomers, unless specifically
excepted, whenever the existence/of/such isomers is possible within the
specific chemical/designation;
(iii) their esters and ethers, unless
specifically excepted, whenever/the/existences of such esters and ethers is
possible;
(iv) their salts, including the salts of esters,
ethers and isomers/ whenever the existence of such salts is possible;
(v) preparations of these
substances, unless exempted by law.
(FROM SCHEDULE IV OF THE CONVENTION ON NARCOTIC DRUGS, 1961)
Acetorphine
|
Acetyl-alpha-methyl-
|
Methyl-3fentanyl
|
Cannabis and
|
Fentanyl
|
Methyl-3 –thio
|
Cannabis resin
|
Alphacetylmethadol
|
fentanyl
|
Desomorphine
|
Alpha-methylfentanyl
|
MPPP
|
Etorphine
|
Beta-hytdroxyfentanyl
|
Para-fluorofentanyl
|
Heroin
|
Beta-hydroxy-methyl-3-
|
PEPAP
|
Ketobemidone
|
Fentanyl
|
Thiofentanyl
|
(FROM SCHEDULE I OF THE CONVENTION ON
PSYCHOTROPIC SUBSTANCES, 1971)
Brolamphetamine
|
Etryptamine
|
Parahexyl
|
Cathinone
|
(+)-Lysergide
|
PMA
|
DET
|
MDA
|
Psilocine, psilotsin
|
DMA
|
Mescaline
|
Psilocybine
|
DMHP
|
Metheathinone
|
Rolicyclidine
|
DMT
|
Methyl-4 aminorex
|
STP, DOM
|
DOET
|
MMDA
|
Tenamphetamine
|
Eticyctidine
|
MDMA
|
Tenocyclidine
|
N-ethyl MDA
|
Tetrahydrocannabmol
|
|
N-hydroxy MDA
|
TMAA
|
SCHEDULE-II
[See clause (XVI) of rule 2]
HIGH RISK DRUGS OF ABUSE
(From Schedule I of the Convention on Narcotic Drugs 1961)
Acetylmethadol
|
Ethylmethyl-
|
Normorphine
|
Alfentanil
|
thiambutene
|
Norpipanone
|
Allylprodune
|
Etonitazene
|
Opium
|
Alphameprodine
|
Etoxeridine
|
Oxycodone
|
Alphamethadol
|
Fentanyl
|
Oxymorphone
|
Adphamethylthio-
|
Furethidine
|
Pethidine
|
Fentanyl
|
Hydrocodone
|
Pethidine
|
Alphaprodine
|
Hydromorphinol
|
intermediate A
|
Anileridine
|
Hydromorphone
|
(4-cyano-i-methyyl-)
|
Benzethidine
|
Hydroxypethidine
|
4-phenyl-piperidine)
|
Benzylmorphine
|
Isomethadone
|
Pethidine
|
Betacetyl methadol
|
Levomethorphean
|
intermediate B
|
Betameprodine
|
Levomoramide
|
(4-phenylpiperidine-4-
|
Betamethadol
|
Levophenacylmorphan
|
carboxylic acid
|
Betaprodine
|
Levorphanol
|
ethyl ester)
|
Bezitramide
|
Metazocine
|
Pethidine
|
Clonitazene
|
Methadone
|
intermediate C
|
Coca (leaf)
|
Methadone intermediate
|
(1-methyl-4-
|
Cocaine
|
(4-cyano-2-dimethyl-
|
phenylpiperidine
|
Codoxime
|
amino-4, 4-diphenyl
|
4-carboxylic acid)
|
Concentrate of poppy
|
butane)
|
Phenadoxone
|
straw
|
Methyldesorphine
|
Phenampromide
|
Dextomoramide
|
Methyldihydromorphine
|
Phenazocine
|
Diampromide
|
Metopon
|
Phenomorphan
|
Diethylthinambutene
|
Moramide
|
Phenoperidine
|
Difenoxin
|
Morphine
|
Piritramide
|
Dihydromorphine
|
Morphine
|
Piritramide
|
Dimenoxadol
|
Morphine methobromide
|
Proheptazine
|
Dimepheptanol
|
and other pemtavalent
|
Properidine
|
Dimethylthiambutene
|
nitrogen morphine
|
Recemethorphan
|
Dioxaphetyl butyrate
|
derivatives
|
Racemoramide
|
Diphenoxylate
|
Morphine-N-oxide
|
Racemorphan
|
Dipipanone
|
Mkypophine
|
Sufentanil
|
Drotebanol
|
Nicomorphine
|
Thebacon
|
Ecgonine
|
Noracymethadol
|
Thebaine
.
|
its esters and
|
Norlevorphanol
|
Tilidine
|
derivatives
|
Normethadone
|
Trimeperidine
|
(From Schedule II of the Convention on
Narcotic Drugs, 1961)
Acetyldigydrocodeine
|
Ethylmorphine
|
Pholocodine
|
Codeine
|
Nicodicodine
|
Propiram
|
Dextropropoxyphene
|
Nicocodine
|
|
Digydrocodeine
|
Norcodeine
|
(From Schedule II of the Convention on
Psychotropic Substances, 1971)
Amphetamine
|
Methamphetamine
|
Phenmetrazine
|
Dexamphetamine
|
Methamphetamine
racemate
|
Secobarbital
|
Fenetylline
|
Methaqualone
|
Zipeprol
|
Levamphetamine
|
Methylphenidate
|
|
Mecloqualone
|
Phencyclidine
|
SCHEDULE-III
[See clause (XXXIII) of rule 2]
RISK DRUGS OF ABUSE
SCHEDULE-III
of the Convention of Psychotropic Substances, 1971
Amobarbital
|
Cathine
|
Pentazocine
|
Buprenorphine
|
Cyclobarbital
|
Pentobarbital
|
Butalbital
|
Glutethimide
|
Flunitrazepam
|
SCHEDULE-IV
of the Convention on Psychotropic Substances,
1971
Allobarbital
|
Ethinamate
|
Methylprylon
|
Alprazolam
|
Ethyl
lofazepate
|
Midazolam
|
Aminorex
|
Etilamphetamine
|
Nimetazepam
|
Amphepramone
|
Fencamfamin
|
Nitrazepam
|
13arbital
|
Fenproporex
|
Nordazepam
|
I
3enzphetarnine
|
Fludiazepam
|
Oxazepam
|
Bromazepam
|
Flurazepam
|
Oxazolam
|
Etrotizolam
|
Halazepam
|
Pemoline
|
B utobarbital
|
Haloxazolam
|
Phendimetrazine
|
Camazepam
|
Ketazolam
|
Phenobarbital
|
Ch
lordiazepoxide
|
Lefetamine
|
Phenterminc
|
Clobazam
|
Loprazolam
|
Pinazepam
|
Clc Irazepam
|
Lorazepam
|
Piptadrol
|
Clo razepate
|
Lormetazepam
|
Prazepam
|
Clo tiazepam
|
Mazindol
|
Pyrovalerone
|
Clonazolam
|
Meazepam
Mefenorex
|
Secbutabarbital
|
Delorazepam
|
Meprobamate
|
Temazepam
|
Diazepam
|
Mesocarb
|
'
Tetrazepam
|
Estazolam
|
Methylpheno-barbital
|
Triazolam
|
Ethclilorvynol
|
Vinylbital
|
SCHEDULE-IV
[See clause (XXXVII of rule 2]
TOXIC CHEMICAL INHALANTS
SCHEDULE-V
CONTROLLED CHEMICALS
This schedule includes:-
(i) the following substances, designated by
their international non-proprietary names or the names used in the
international conventions in force;
(ii) the
salts of these substances, whenever the existence of such salts is
possible, with the exception of sulphuric acid and hydrochloric acid.
DIVISION I
(Table I of 1988 Convention)
Ephdrine
|
N-acetylanthranilic acid
|
Ergometrine
|
Isosafrole
|
Ergotamine
|
3,4 methylenedioxyphenyl
|
Lysergic Acid
|
2 Propanone
|
4-Phenyl-2-Propanone
|
Piperonal
|
Pseudoephedrine
|
Safrole
|
DIVISION II
(Table II of the 1988 Convention)
Acetic anhydride
|
Hydrochloric acid
|
Acetone
|
Methyl ethyl
|
Anthranilic acid
|
Ketone
|
Ethyl ether
|
Pctassium permanganate
|
phenylacetic acid
|
Sulphuric acid
|
Piperidine
|
Toluene
|
SCHEDULE –VI
[See clauses (VI) and (VII) of rule 2]
DIVISION-I—CONTROLLED EQUIPMENT
Encapsulating
machines
Tabletting
machines
Rotary
evaporators
Laboratory equipment
with a capacity for large volume production (e.g. round bottom flasks of 25
liters or above and related condensers, separating funnels and heating apparatus)
DIVISION-2—CONTROLLED MATERIAL
Gelatin
capsules
[eg
glucose, lactose, phenolphthalein]
[prescribed
bulking agents eg magnesium stearate, calcium oxide ("talc")] [colouring materials or
food dyes]
Annexure -I
Annexure - II
Annexure - III
Annexure - IV
Annexure - V
Annexure - VI
Annexure - VII
Annexure - VIII
Annexure – IX
Note: For Annexure
please see Gazette of Pakistan, Extraordinary, Part II, Pages No. 2775 to 2797, dated 28-11-2001.
Pak Law: Control Of Narcotic Substances (Regulation Of Drugs Of Abuse, Controlled Chemicals, Equipment And Materials) Rules, 2001. >>>>> Download Now
ReplyDelete>>>>> Download Full
Pak Law: Control Of Narcotic Substances (Regulation Of Drugs Of Abuse, Controlled Chemicals, Equipment And Materials) Rules, 2001. >>>>> Download LINK
>>>>> Download Now
Pak Law: Control Of Narcotic Substances (Regulation Of Drugs Of Abuse, Controlled Chemicals, Equipment And Materials) Rules, 2001. >>>>> Download Full
>>>>> Download LINK Jc